Cocaine Abuse in the NBA: A Dark Era Revealed in Micheal Ray Richardson's Memoir

US
Published:

The publication of Micheal Ray Richardson's memoir, "Banned," has revived discussions surrounding an unsettling period in NBA history characterized by rampant drug use. Richardson, known for being the first player banned from the league due to drug abuse, reflects on an era when over 40% of players reportedly used cocaine.

The memoir recalls a notable incident from 1984, where a young Michael Jordan, upon arriving at a hotel in search of teammates, stumbled into a scene rife with drug use. Jordan recalled feeling alarmed and quickly deciding to leave, realizing the potential consequences if authorities intervened.

Richardson's career, although not marked by superstardom, was significantly impacted by substance abuse. He was regarded as a talented point guard, earning four All-Star selections, yet saw his career cut short in 1986 when he received a lifetime ban after failing multiple drug tests. This decision by then-NBA commissioner David Stern marked a turning point, signaling the end of the league's unchecked excess.

Richardson's revelations echo earlier estimates by publications such as The Washington Post, which in 1980 estimated that drug use in the league was alarmingly high, with some sources suggesting that between 40% and 75% of players were involved in cocaine use at the time.

The era also saw other tragic stories emerge, including the fate of Len Bias, a promising player who died of a cocaine-related cardiac event shortly after being drafted by the Boston Celtics in 1986.

In response to the crisis, Stern implemented strict drug testing and rehabilitation programs, altering the league's culture surrounding substance use. In more recent developments, the NBA has shifted its approach to cannabis, as evidenced by a new agreement allowing for the use of marijuana for recreational purposes, indicative of changing attitudes within the league.

Richardson's insights serve as a sobering reminder of a turbulent chapter in the NBA's history, with ongoing implications for the league's image and policies today.

Weekly Newsletter

News summary by melangenews

Loading...

More from United States

Tragic Collision of Passenger Plane and Military Helicopter in Washington Claims 67 Lives

A catastrophic midair collision between a passenger plane and a military helicopter in Washington D.C. on Wednesday resulted in the deaths of all 67 individuals on board. The incident involved American Airlines flight 5342, which was a Bombardier CRJ-700 carrying 60 passengers and four crew members, and a military Sikorsky H-60 Black Hawk helicopter occupied by three service members. The collision occurred over the Potomac River at approximately 8:48 PM local time while the plane was making its final approach to Ronald Reagan Airport. Eyewitness reports indicated that the helicopter veered dangerously close to the aircraft before the impact, causing both to explode in midair. Emergency teams recovered 28 bodies from the plane and one from the helicopter, confirming that no survivors emerged from the wreckage. American Airlines expressed its condolences and stated that it is cooperating with investigation efforts, while President Donald Trump commented on the tragedy, stating it "seemed avoidable" given the clear weather conditions and routine approach procedure. A joint investigation by civil and military authorities is underway to determine the accident's cause.
US

FDA Approves Revolutionary Bioengineered Blood Vessel for Trauma Treatments

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking bioengineered blood vessel aimed at addressing the needs of trauma patients. Developed by North Carolina-based Humacyte, this vessel is designed to integrate with a patient’s body over time, providing a solution for individuals who have suffered severe injuries that impede blood circulation, particularly in cases of amputation. According to founder and CEO Laura Niklason, traditional treatments using veins are often inadequate, especially when patients cannot provide usable options from their own bodies. The FDA approval follows extensive testing involving 51 civilian and 16 military patients, revealing that nearly 92% of the engineered vessels remained functional after 30 days, compared to 79% for synthetic alternatives. Additionally, the infection rate for the bioengineered vessels was under 1%, significantly lower than the over 8% rate associated with synthetic grafts, as published in the journal JAMA Surgery. While the approved application is limited to trauma cases, Humacyte is exploring additional uses for its technology, including potential applications in kidney dialysis and peripheral artery disease.
US

Trump Plans to Detain 30,000 Migrants at Guantanamo Bay

Former President Donald Trump has outlined a controversial plan to detain up to 30,000 migrants at the Guantanamo Bay detention facility if he is re-elected in 2024. According to a statement released by Trump's campaign, this measure aims to address illegal immigration and bolster national security. This proposal comes amidst intensifying discussions on immigration policies in the United States, reflecting Trump's previously embraced hardline stance during his presidency. Trump's administration was marked by strict immigration measures, including family separations and the construction of barriers along the U.S.-Mexico border. Critics of the plan have raised concerns about humanitarian implications and the legality of detaining a large number of migrants indefinitely. Legal experts argue that such actions could face significant pushback in courts. The proposal reflects a broader trend among certain political leaders advocating for stringent immigration control as a response to increasing cross-border migration. As the 2024 presidential election approaches, Trump's immigration policy is expected to be a focal point of debate among candidates.
US
All United States News ->